11例慢性淋巴细胞白血病合并第二肿瘤的临床分析

doi:10.3969/j.issn.1000-8535.2023.06.004

广州医药 ›› 2023, Vol. 54 ›› Issue (6): 23-27.DOI: 10.3969/j.issn.1000-8535.2023.06.004

11例慢性淋巴细胞白血病合并第二肿瘤的临床分析

杨方方, 邓婷芬, 向琪, 李昕芯, 张玉玲, 王顺清

广州市第一人民医院,华南理工大学附属第二医院（广州 510180）

收稿日期:2022-09-07 出版日期:2023-06-20 发布日期:2023-07-27

Clinical analysis of 11 cases of chronic lymphocytic leukemia patients with second tumor

YANG Fangfang, DENG Tingfen, XIANG Qi, LI Xinxin, ZHANG Yuling, WANG Shunqing

Department of Hematology,Guangzhou First People's Hospital / The Second Affiliated Hospital of South China University of Technology,Guangzhou 510180,China

Received:2022-09-07 Online:2023-06-20 Published:2023-07-27

摘要/Abstract

摘要： 目的探讨慢性淋巴细胞白血病（CLL）合并第二肿瘤临床特征和预后。方法回顾性分析2015年8月—2021年10月我院收治的58例CLL患者,其中有11例合并第二肿瘤,47例无合并第二肿瘤,分析两组病例的临床特征及其对预后的影响。结果 CLL合并第二肿瘤和无合并第二肿瘤患者在年龄、性别、白细胞计数、血红蛋白水平、淋巴细胞计数、血小板计数、乳酸脱氢酶（LDH）、β₂-微球蛋白（β₂-MG）水平、分期、单个基因缺失类型之间比较差异无统计学意义,但CLL合并第二肿瘤患者基因缺失个数较无合并第二肿瘤CLL患者组高（χ²=11.17,P=0.03）,且总生存期较短。结论 CLL合并第二肿瘤患者常伴有多个基因缺失,且预后差,当CLL患者伴有多个基因缺失时,在诊治过程中需警惕有无合并第二肿瘤。

关键词: 慢性淋巴细胞白血病, 第二肿瘤, 基因缺失

Abstract: Objective To investigate the prognosis and clinical characteristics of chronic lymphocytic leukemia（CLL）patients with second tumor．Methods A retrospective analysis was performed on 58 cases of CLL patients who were diagnosed in our hospital from August 2015 to October 2021．The clinical data of 11 CLL patients with second cancer and 47 CLL patients without second cancer were compared and analyzed．Results There were no significant differences in age,sex,white blood cell count,lymphocyte count,platelet count,the level of serum β₂-microglobulin and lactate dehydrogenase between two groups．However,in CLL patients with second cancer,the incidence of multiple genetic deletions was higher than those without second cancer（χ² =11.17,P =0.03）．The overall survival time was shorter in CLL patients with second primary cancer．Conclusions CLL patients with second tumor have a frequent multiple gene deletions and poor prognosis．Physicians should pay attention to second cancers when diagnosing the CLL patients with multiple gene deletions．

Key words: chronic lymphocytic leukemia, second cancers, gene deletion

杨方方, 邓婷芬, 向琪, 李昕芯, 张玉玲, 王顺清. 11例慢性淋巴细胞白血病合并第二肿瘤的临床分析[J]. 广州医药, 2023, 54(6): 23-27.

YANG Fangfang, DENG Tingfen, XIANG Qi, LI Xinxin, ZHANG Yuling, WANG Shunqing. Clinical analysis of 11 cases of chronic lymphocytic leukemia patients with second tumor[J]. Guangzhou Medical Journal, 2023, 54(6): 23-27.

参考文献

[1] ZHENG G,CHATTOPADHYAY S,SUD A,et al.Second primary cancers in patients with acute lymphoblastic,chronic lymphocytic and hairy cell leukaemia[J].Br J Haematol,2019,185(2):232-239.
[2] 吴瞳,李增军,邱录贵.慢性淋巴细胞白血病与第二肿瘤的研究进展[J].临床血液学杂志,2009,22(11):629-631.
[3] DASANU C A,ALEXANDRESCU D T.Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia[J].Med Gen Med,2007,9(4):35.
[4] 张之南,沈悌.血液病诊断及疗效标准[M].第4版.北京:科学出版社,2007:139-143.
[5] BACHER U,KERN W,SCHOCH C,et al.Discrimination of chronic lymphocytic leukemia(CLL)and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization(FISH)[J].Ann Hematol,2004,83(6):349-355.
[6] FITZTHUM A D,WAKELY P E.Chronic lymphocyti-cleukemia and second primary nonlymphoid malignancies:cytopathologic study of 17 cases[J].J Am Soc Cytopathol,2021,10(3):321-327.
[7] ROBAK T,BLONSKI J Z,GORA-TYBOR J,et al.Second malignancies and Richter’s syndrome in patients with chronic lymphocytic leukaemia treated with cladribine[J].Eur J Cancer,2004,40(3):383-389 .
[8] 吴纬宇,董洪军,尹晓雅,等.慢性淋巴细胞白血病伴面部多发性鳞状细胞癌1例[J].临床皮肤科杂志,2021,50(1):30-32.
[9] SCHÖLLKOPF C,ROSENDAHL D,ROSTGAARD K,et al.Risk of second cancer after chronic lymphocytic leukemia[J].Int J Cancer,2007,121(1):151-156.
[10] 杨倩,黄俊霞,聂淑敏,等.伊布替尼治疗慢性淋巴细胞白血病合并第二肿瘤二例并文献复习[J].白血病·淋巴瘤,2020(3):185-187.
[11] MULLIGAN S P,SHUMACK S,GUMINSKI A.Chronic lymphocytic leukemia,skin and other second cancers[J].Leuk Lymphoma,2019,60(13):3104-3106.
[12] RIPOLLÉS L,ORTEGA M,ORTUÑO F,et al.Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia[J].Cancer Genet Cytogenet,2006,171(1):57-64.
[13] 张海英,杨艳丽,赵强,等.荧光原位杂交技术检测慢性淋巴细胞白血病分子遗传学异常[J].中国实验血液学杂志,2020,28(5):1474-1479.
[14] WONG K F,SIU LISA L P,WONG W S.Double minutes and MYC amplification:a combined May-Grunwald Giemsa and fluorescence in situ hybridization study[J].Am J Clin Pathol,2014,141(2):280-284.
[15] CHILLEMI G,KEHRLOESSER S,BERNASSOLA F,et al.Structural evolution and dynamics of the p53 proteins[J].Cold Spring Harb Perspect Med,2017,7(4):a028308.
[16] 王丹,陈昀,郭农建.同时诊断慢性淋巴细胞白血病及恶性实体瘤2例[J].临床血液学杂志,2017,30(7):551-555.
[17] 荆源,林樉,王芳婷,等.荧光原位杂交技术检测43例慢性淋巴细胞白血病患者基因异常[J].中国实验血液学杂志,26(4):1038-1043.
[18] JIANG H,REINHARDT H C,BARTKOVA J,et al.The combined status of ATM and p53 link tumor development with therapeutic response[J].Genes Dev,2009,23(16):1895-1909.
[19] AMBROSE M,GATTI RICHARD A.Pathogenesis of ataxia-telangiectasia:the next generation of ATM functions[J].Blood,2013,121(20):4036-4045.
[20] 崔美玲,布日古德,马金柱.共济失调毛细血管扩张突变基因与恶性肿瘤关系研究进展[J].医学综述,2020,26(6):1109-1113.
[21] DONEDA L,MONTILLO M,INTROPIDO L,et al.Interphase fluorescence in situ hybridization analysis of del(11)(q23)and del(17)(p13)in chronic lymphocytic leukemia.a study of 40 early-onset patients[J].Cancer Genet Cytogenet,2003,140(1):31-36.
[22] 吕瑞,李增军,李姮.FISH检测12号染色体三体阳性慢性淋巴细胞白血病70例临床分析[J].中华血液学杂志,2018,39(5):387-391.

11例慢性淋巴细胞白血病合并第二肿瘤的临床分析

Clinical analysis of 11 cases of chronic lymphocytic leukemia patients with second tumor

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价